Showing results (31-40 of 39) with videos related to
Sort By:
Pageof 4
You have reached the last page of results.This site can display upto 39 results.
Bioorganic & Medicinal Chemistry|August 10, 2016
Arylazolyl(azinyl)thioacetanilides. Part 20: Discovery of novel purinylthioacetanilides derivatives as potent HIV-1 NNRTIs via a structure-based bioisosterism approachXueyi Lu, Xiao Li, Jiapei Yang, et al.Nature Communications|December 22, 2022
Slight compositional variation-induced structural disorder-to-order transition enables fast Na<sup>+</sup> storage in layered transition metal oxidesYuansheng Shi, Pengfeng Jiang, Shicheng Wang, et al.ACS Nano|May 13, 2020
On/Off Boundary of Photocatalytic Activity between Single- and Bilayer MoS<sub>2</sub>Takaaki Taniguchi, Leanddas Nurdiwijayanto, Shisheng Li, et al.Advanced Science (Weinheim, Baden-Wurttemberg, Germany)|December 17, 2016
High-Performance Li-O<sub>2</sub> Batteries with Trilayered Pd/MnO <i></i> /Pd NanomembranesXueyi Lu, Junwen Deng, Wenping Si, et al.ACS Nano|February 7, 2024
Sustainable Anionic Redox by Inhibiting Li Cross-Layer Migration in Na-Based Layered Oxide CathodesYuansheng Shi, Fushan Geng, Yang Sun, et al.Advanced Science (Weinheim, Baden-Wurttemberg, Germany)|June 9, 2021
Tunable Doping of Rhenium and Vanadium into Transition Metal Dichalcogenides for Two-Dimensional ElectronicsShisheng Li, Jinhua Hong, Bo Gao, et al.Journal of Medicinal Chemistry|August 20, 2016
Design, Synthesis, and Evaluation of Thiophene[3,2-d]pyrimidine Derivatives as HIV-1 Non-nucleoside Reverse Transcriptase Inhibitors with Significantly Improved Drug Resistance ProfilesDongwei Kang, Zengjun Fang, Zhenyu Li, et al.Journal of Medicinal Chemistry|May 9, 2017
Structure-Based Optimization of Thiophene[3,2-d]pyrimidine Derivatives as Potent HIV-1 Non-nucleoside Reverse Transcriptase Inhibitors with Improved Potency against Resistance-Associated VariantsDongwei Kang, Zengjun Fang, Boshi Huang, et al.Journal of Medicinal Chemistry|July 3, 2018
Optimization of N-Substituted Oseltamivir Derivatives as Potent Inhibitors of Group-1 and -2 Influenza A Neuraminidases, Including a Drug-Resistant VariantJian Zhang, Vasanthanathan Poongavanam, Dongwei Kang, et al.Pageof 4